What the industry is the first person to eat crabs, domestic medical monitor, one of the main suppliers and zondan, eat the crabs.
July 27 and zondan in angel off officially opened all the chips, also announced that the new board will be listed, it is angel off first proposed listing of the new board of medical device project. Hexin zondan is a rising star in the field of domestic high-end medical equipment manufacturing, is the field in recent years, the development of the fastest emerging enterprises.
Leveraging the public equity raise, three new board target
In the general cognitive, high-end medical equipment manufacturing that reads are mouthful of tall industry and public equity raised platform does not seem to have to do. Public equity raise is generally considered to be more suitable for B2C business, similar and zondan do B2B companies rarely appeared on equity raise public platform. But the capital market has always only pay attention to whether need, without the so-called mixed mix. And zondan at this time landing Angel guest, has its own unique considerations.
According to the plan and zondan, 2015 August 31, as the date of the share reform benchmarks, before the end of October to the small and medium-sized enterprise share transfer system application materials, is expected in 2016 completed in the first quarter of the new Sanban listed. The new board has several medical device manufacturing enterprises listed, but mixed, and zondan such heavyweights join may impact on the plate.
The off angel of 700 million in a round of financing, may will be Hexin zondan sprint before the new board of the last round of financing, the project has received Huaao lead investor capital.
China and Macao capital is an experienced investment in the Institute of biological medical field, early in May this year has advanced and zondan were round 800 million yuan investment. Prior to the investment case, there have been more than a dozen companies landing small plates, the gem, the new board, or with the listing Corporation to complete the acquisition. The epoch of capital invested heavily and zondan, also reflects on the heart and optimistic about the capital.
According to the published public funding programmes, if stop 2016 June 30 and zondan if not yet launched three new board, large shareholders commitment by 12% in the repo rate. This means that investors guaranteed rate of return has been with P2P public debt raised almost, such favorable conditions of repurchase is extremely rare in the public to raise equity, and zondan the can be described as determined to win.
Technology leading domestic market Dongfeng quietly to
The purpose of this round of financing, and zondan explained that the company technology has reached a mature stage, the company is in the period of market expansion, but because of the limited investment in research and development is too large, sales network to expand rapidly, the rapid expansion of market share has become a top priority.
In fact, on and zondan, this is a very critical window. After the completion of the financing, the company will be the first to increase investment in the sales team.
And zondan provide data show that in 2014 and zondan in domestic and foreign markets have a good performance, sales amounted to 25 million yuan, of which 26% for overseas sales, evident in the high-end medical monitor market expansion of the momentum.
This year, and zondan is expected to can realize sales income of 45 million yuan. Among them, neonatal monitor as currently has received the fist product of market acceptance, expected sales of up to 1000 million yuan; transport monitor amounted to 600 million yuan, multi parameter monitor in the secondary hospital widely, is expected to 2015 with annual sales of up to 25 million yuan. The high-end market, the operating room monitor in 3 armour hospital and department experts widely expected with annual sales of up to 400 million yuan.
In the foreseeable future, the market is expected to further expand the scale of the monitor. Data shows, at present China bed tens of 10% per year increase, calculated according to the current level of monitor ratio 20%, monitor every year increase in the number of 9 million units; monitor every five years to replace a each year to replace 18 million units, so every year to monitor the size of the market for 27 million units. And if the calculated by reference to the countries in Europe and America, 80% of the blending ratio, enhance the penetration rate of monitor can bring potential market space is 30-40 million units.
In view of the broad market prospects, and zondan presents very optimistic about sales growth target, to 2017 sales will reach 1.5 billion yuan, while achieving 25 million yuan of profits. If the smooth realization of the goal, and zondan is expected to leveraging public equity raise quickly into the ranks of the first-line brand, the investor will receive handsome returns.